Progressive supranuclear palsy: Setting the scene for therapeutic trials

Editorial

Andrew Siderowf et al. Neurology. 2003.

. 2003 Mar 25;60(6):892-3.

doi: 10.1212/01.wnl.0000059563.84990.db.

No abstract available

Comment on

Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study.
Nath U, Ben-Shlomo Y, Thomson RG, Lees AJ, Burn DJ. Nath U, et al. Neurology. 2003 Mar 25;60(6):910-6. doi: 10.1212/01.wnl.0000052991.70149.68. Neurology. 2003. PMID: 12654952
Progression of gait, speech and swallowing deficits in progressive supranuclear palsy.
Goetz CG, Leurgans S, Lang AE, Litvan I. Goetz CG, et al. Neurology. 2003 Mar 25;60(6):917-22. doi: 10.1212/01.wnl.0000052686.97625.27. Neurology. 2003. PMID: 12654953
Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy.
Seppi K, Schocke MF, Esterhammer R, Kremser C, Brenneis C, Mueller J, Boesch S, Jaschke W, Poewe W, Wenning GK. Seppi K, et al. Neurology. 2003 Mar 25;60(6):922-7. doi: 10.1212/01.wnl.0000049911.91657.9d. Neurology. 2003. PMID: 12654954